NCT03278119View on ClinicalTrials.gov

Sleep Aging and Risk for Alzheimer's 2.0

Active, not recruitingOBSERVATIONAL
Enrollment

158

Participants

Timeline

Start Date

May 1, 2018

Primary Completion Date

December 25, 2025

Study Completion Date

December 25, 2025

Conditions
Alzheimer DiseaseSleep Apnea
Interventions
DIAGNOSTIC_TEST

PET Scan and nocturnal polysomnography

Amyloid PET scans will be used to assess amyloid burden in the brain, and nocturnal polysomnography will be used to assess sleep and cardiopulmonary variables

Trial Locations (1)

10016

Healthy Brain Aging and Sleep Center, New York

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

NYU Langone Health

OTHER

NCT03278119 - Sleep Aging and Risk for Alzheimer's 2.0 | Biotech Hunter | Biotech Hunter